BiotechTube

Diazepam Buccal Film

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Epilepsy

Conditions

Epilepsy

Trial Timeline

Aug 31, 2017 → Mar 11, 2020

NCT ID
NCT03222349

About Diazepam Buccal Film

Diazepam Buccal Film is a phase 2 stage product being developed by Aquestive Therapeutics for Epilepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT03222349. Target conditions include Epilepsy.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03222349Phase 2Completed

Competing Products

20 competing products in Epilepsy

See all competitors
ProductCompanyStageHype Score
perampanelEisaiPhase 2
52
LacosamideUCBPhase 3
74
Zonisamide + PlaceboEisaiPhase 3
77
ZonegranEisaiApproved
85
perampanel + perampanelEisaiPhase 1
33
Perampanel + PlaceboEisaiApproved
85
perampanelEisaiApproved
85
E2007 + PlaceboEisaiPhase 2
52
Placebo + RufinamideEisaiPhase 3
77
E2007 (perampanel) + PlaceboEisaiPhase 2
52
Perampanel Oral TabletEisaiApproved
85
perampanelEisaiPhase 3
77
PerampanelEisaiPre-clinical
23
Zonisamide + CarbamazepineEisaiPhase 3
77
PerampanelEisaiApproved
85
Perampanel and Microgynon-30 + Perampanel and Microgynon-30EisaiPhase 1
33
PerampanelEisaiPhase 2
52
Zonisamide + PlaceboEisaiPhase 3
77
zonisamide low dose group + zonisamide high dose groupEisaiApproved
85
E2007 + E2007 + PlaceboEisaiPhase 2
52

Other Products from Aquestive Therapeutics

Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight categoryPhase 3
69
Riluzole Oral Soluble film (ROSF) 50 mgPhase 2
44
Diazepam Buccal Film 12.5 mgPhase 2
44
Riluzole Oral Soluble FilmPhase 2
44
DESF + Epinephrine InjectionPhase 2
44